Regeneron Pharmaceuticals
REGN
#169
Rank
$80.17 B
Marketcap
$736.23
Share price
0.12%
Change (1 day)
14.44%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2022 (TTM): $6.03 B

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $6.03 B. In 2021 the company made an earning of $9.32 B an increase over its 2020 earnings that were of $3.81 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$6.03 B-35.26%
2021$9.32 B144.75%
2020$3.81 B56.86%
2019$2.42 B-4.87%
2018$2.55 B22.85%
2017$2.07 B56.3%
2016$1.32 B8.55%
2015$1.22 B57.92%
2014$0.77 B8.75%
2013$0.71 B72.13%
2012$0.41 B-285.93%
2011-$0.23 B121.3%
2010-$0.11 B30.6%
2009-$77.13 M-9.88%
2008-$85.59 M-25.23%
2007-$0.12 B6.32%
2006-$0.11 B-186.52%
2005$0.12 B2103.7%
2004$5.64 M-105.75%
2003-$98.16 M-19.52%
2002-$0.13 B47.09%
2001-$82.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$22.51 B 272.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.58 B 290.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.72 B 28.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.65 B 43.32%๐Ÿ‡ซ๐Ÿ‡ท France
$3.39 B-43.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.02 B-116.85%๐Ÿ‡บ๐Ÿ‡ธ USA